Examkin

Soru

Zorluk: ZorCardiovascular System

A 73-year-old man presents to the primary care clinic reporting progressively worsening swelling in his legs and an uncomfortable sensation of fullness in his abdomen over the last six weeks. He also notes that he now becomes breathless after walking just one block, which represents a significant decline from his previous baseline. His medical history is significant for chronic bronchitis and a 50-pack-year smoking history. His only current medication is an albuterol inhaler used as needed. His pulse is 95/min, respiratory rate is 20/min, and blood pressure is 120/78 mmHg. Pulse oximetry shows an oxygen saturation of 87% on room air. Physical examination reveals marked jugular venous distention with prominent 'v' waves. Cardiac auscultation demonstrates a prominent right ventricular heave and a grade 3/6 holosystolic murmur at the lower left sternal border that intensifies with deep inspiration. Pulmonary auscultation reveals a prolonged expiratory phase with diffuse rhonchi, but no crackles are heard. The liver is palpated 4 cm below the right costal margin and is tender. There is 3+ pitting edema of the lower extremities extending up to the knees. Which of the following interventions is most likely to prolong this patient's survival?

  1. Continuous supplemental oxygen therapyCevap
  2. B
    Oral furosemide therapy
  3. C
    Oral lisinopril therapy
  4. D
    Oral metoprolol succinate therapy
  5. E
    Oral bosentan therapy

Cevap

Continuous supplemental oxygen therapy
The correct answer is continuous supplemental oxygen therapy. This patient presents with classic signs of cor pulmonale, which is right ventricular enlargement and failure secondary to a primary pulmonary disorder. His severe chronic obstructive pulmonary disease (COPD) has led to chronic alveolar hypoxia, triggering hypoxic pulmonary vasoconstriction and subsequent pulmonary hypertension. The increased right ventricular afterload eventually results in right-sided heart failure, evidenced by his jugular venous distention, right ventricular heave, tricuspid regurgitation murmur, hepatomegaly, and peripheral edema. According to established guidelines, patients with COPD who have a resting oxygen saturation of 88% or less, or 89% or less with evidence of right heart failure or polycythemia, qualify for long-term supplemental oxygen therapy. This therapy has been definitively proven to reduce mortality in this patient population by reversing pulmonary vasoconstriction, thereby decreasing pulmonary vascular resistance and offloading the failing right ventricle.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and physical examination findings.
The patient has a history of severe COPD, resting hypoxemia (SaO2 87%), and definitive signs of isolated right-sided heart failure including jugular venous distention, a right ventricular heave, a tricuspid regurgitation murmur, hepatomegaly, and severe peripheral edema. Lung fields are clear of crackles, arguing against left-sided heart failure.
To establish the primary diagnosis of cor pulmonale secondary to chronic hypoxemic lung disease.
2
Identify the primary mechanism driving the cardiovascular pathology.
Chronic alveolar hypoxia has caused hypoxic pulmonary vasoconstriction, leading to elevated pulmonary vascular resistance, pulmonary hypertension, and subsequent right ventricular failure.
Understanding the underlying pathophysiology ensures the selected treatment targets the root cause rather than just downstream symptoms.
3
Determine the optimal intervention to improve long-term survival for this specific pathology.
Long-term continuous supplemental oxygen therapy is indicated for COPD patients with severe resting hypoxemia (SaO2 ≤ 88%) or signs of right heart failure. It reverses hypoxic pulmonary vasoconstriction and is proven to decrease mortality.
To strictly answer the question, which asks for the intervention that prolongs survival, not merely provides symptomatic relief.

Anahtar Kavram

In patients with cor pulmonale secondary to chronic obstructive pulmonary disease, long-term continuous supplemental oxygen therapy is the primary intervention proven to prolong survival when resting hypoxemia (SaO2 ≤ 88% or PaO2 ≤ 55 mmHg) is present.
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru